Navigation Links
4 new genes identified for Alzheimer's disease risk
Date:4/3/2011

Mount Sinai School of Medicine researchers are part of a consortium that has identified four new genes that when present increase the risk of a person developing Alzheimer's disease later in life. The findings appear in the current issue of Nature Genetics. The consortium also contributed to the identification of a fifth gene reported by other groups of investigators from the United States and Europe.

"Mount Sinai has unique resources that we contributed to the study, having one of the largest brain banks for Alzheimer samples in the world," said lead Mount Sinai scientist, Joseph Buxbaum, PhD, Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at Mount Sinai School of Medicine. "Follow up studies of the genes identified, to determine how they affect brain biochemistry, are now possible in our samples, and this can help us understand how the genes contribute to Alzheimer's disease"

The study, conducted by the Alzheimer's Disease Genetics Consortium, consisting of investigators from 44 universities and research institutions in the United States, and led by Gerard D. Schellenberg, PhD, at Penn, with primary analysis sites at Miami, led by Margaret A. Pericak-Vance, PhD, and Boston, led by Lindsay A. Farrer, PhD, analyzed more than 11,000 people with Alzheimer's disease and nearly the same number of elderly people who have no symptoms of dementia. Three additional institutions contributed confirming data, bringing the total number of people analyzed in the study to over 54,000.

The researchers had two main goals for the study. First was the identification of new Alzheimer's disease genes to provide major clues as to its underlying cause. Genetic studies can provide new insights into the molecules at the center of the disease. Obtaining this type of understanding is critical for drug discovery, since the treatments currently available to patients are only slightly effective.

The second goal
'/>"/>

Contact: Ian Michaels
Ian.Michaels@MountSinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Butterfly study reveals traits and genes associated with establishment of new populations
2. New study pinpoints why some microbial genes are more promiscuous than others
3. Dine or dash? Genes help decide when to look for new food
4. Study shows how plants sort and eliminate genes over millennia
5. An Israel prize in his genes
6. Suggesting genes friends, Facebook-style
7. David and Goliath viruses shed light on the origin of jumping genes: UBC study
8. Better brain wiring linked to family genes
9. University of Maryland School of Medicine study identifies genes associated with binge drinking
10. U. Iowa team investigates function of junk DNA in human genes
11. Just like cars, developmental genes have more than 1 way to stop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/5/2015)... 2015 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends and ... recognition is forecast to reach US$ 2,671.8 Mn by ... surveillance systems by civil and government agencies. This is ... terrorist activities across the globe that would elevate the ...
(Date:8/4/2015)... 04, 2015 ... announced the addition of the "Digital ... Service), Sub-Segment (Computer Forensics, Network Forensics, Mobile ... Service, Vertical and Region - Global Forecast ... By Component (Hardware, Software, and ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... research from North Carolina State University provides molecular-level insights ... on Earth and the main structural component of plant ... "bio-oils" which can be refined into any number of ... car or an airplane. Using a supercomputer that ...
... Mich. --- Researchers have found the first proof that ... to suicidal behavior, offering new hope for efforts to ... in the journal Neuropsychopharmacology , Michigan State University,s ... the first evidence that glutamate is more active in ...
... analysis has revealed that many Amazon tree species are likely ... to previous findings that temperature increases would cause them to ... of Ecology and Evolution , reveals the surprising age ... years and therefore shows that they have survived previous ...
Cached Biology News:Study fuels insight into conversion of wood to bio-oil 2Countering brain chemical could prevent suicides 2Warming climate unlikely to cause extinction of ancient Amazon trees, study finds 2
(Date:8/31/2015)... SAN FRANCISCO, Calif. , Aug. 31, 2015 /PRNewswire/ ... the discovery and development of novel cancer immunotherapies, announced ... M.D., Ph.D., as Chief Executive Officer and William ... Wong and Ho join an experienced management team led ... Jordan Fridman , Ph.D., Chief Scientific Officer; ...
(Date:8/31/2015)... , ... August 31, 2015 , ... There’s a new ... Minerva is the first commercially available new FDA approved system in the last 14 ... of 92%, the high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction ...
(Date:8/28/2015)... ... 28, 2015 , ... Proove Biosciences , a commercial ... Spine Intervention Society’ s 23rd Annual Scientific Meeting (ASM). The ASM event ... focus on evidence-based research and clinical application, the event gathered industry thought leaders ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... opportunity for venture capital funds, investment firms and animal health companies to hear ... have raised $160 million. Several have also received licensing agreements or distribution contracts. ...
Breaking Biology Technology:FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 13 ... is covered by 44 percent of commercial health plans ... to the Formulary Forum report entitled Formulary Advantages ... and Future DPP-IV Inhibitors and GLP-1 Analogues on Advantaged ...
... JOLLA, Calif., Oct. 13 CalciMedica, a biotechnology company ... autoimmune and inflammatory diseases, announced today that Evelyn Graham, ... been appointed as an independent director of the Company. ... strategy and advance its lead drug program toward the ...
... 13 Systagenix Wound Management has,announced the formation of ... of multi-disciplinary and highly respected wound care clinicians and,practitioners ... by,Systagenix,s newly appointed Medical Director, Dr Robert Snyder. , ... thought leaders in the,wound care field, the Systagenix Medical ...
Cached Biology Technology:Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes 2CalciMedica Appoints Evelyn Graham to its Board of Directors 2Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care 2Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care 3Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care 4Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care 5Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care 6
Glycerokinase; from Bacillus stearothermophilus...
A compact, high-speed single tube reader unit designed for benchtop 2D barcode reading. The unit can be used with all of ABgene's 2D barcoded tubes, including the 2ml CryoCode tube....
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
... enzyme that catalyzes the conversion,of starch ... maltotriose and,dextrins. The level of a-amylase ... are of clinical importance,1-3 while plant ... industry.4, The EnzChek Amylase Assay Kit ...
Biology Products: